potactasol
actavis group ptc ehf - topotekanas - uterine cervical neoplasms; small cell lung carcinoma - antinavikiniai vaistai - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. topotecan kartu su cisplatina skiriamas pacientams su karcinomos, gimdos kaklelio periodinis po radioterapijos ir pacientams, sergantiems etape ivb ligos. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.
co-trimoxazol actavis
actavis nordic a/s - sulfametoksazolas/trimetoprimas - tabletės - 400 mg/80 mg - sulfamethoxazole and trimethoprim
diamilla
actavis group ptc ehf. - dezogestrelis - plėvele dengtos tabletės - 75 µg - desogestrel
gembin
actavis group ptc ehf. - gemcitabinas - koncentratas infuziniam tirpalui - 40 mg/ml - gemcitabine
gliclazide actavis
teva b.v. - gliklazidas - modifikuoto atpalaidavimo tabletės - 30 mg; 60 mg - gliclazide
tercef
actavis group ptc ehf. - ceftriaksonas - milteliai injekciniam ar infuziniam tirpalui - 1 g - ceftriaxone
efisol
actavis group ptc ehf. - dekvalinio chloridas/askorbo rūgštis - suslėgtosios pastilės - 0,25 mg/30 mg - dequalinium
finasteride actavis
lex ano, uab - finasteridas - plėvele dengtos tabletės - 5 mg - finasteride
valsartan hct actavis
teva b.v. - valsartanas/hidrochlorotiazidas - plėvele dengtos tabletės - 160 mg/25 mg; 80 mg/12,5 mg; 160 mg/12,5 mg - valsartan and diuretics
imipenem/cilastatin actavis
teva b.v. - imipenemas/cilastatinas - milteliai infuziniam tirpalui - 500 mg/500 mg - imipenem and cilastatin